Xiao-Dong Jiao

1 article listing Xiao-Dong Jiao in Nature Communications, indexed by Paperzzz from Crossref and OSF.

1. Anlotinib plus toripalimab as a first-line treatment in patients with advanced gastric cancer and performance status 2: the phase II APICAL-GC trial Nature Communications